Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
SNYR
Synergy CHC Corp
SNYR
Market cap
$4.52M
Overview
Fund Trends
Analyst Outlook
Journalist POV
0.3999
USD
-0.0445
10.01%
At close
Updated
Apr 23, 4:00 PM EDT
Pre-market
After hours
0.4097
+0.0098
2.45%
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
-10.01%
5 days
-17.67%
1 month
-65.82%
3 months
-78.5%
6 months
-84.38%
Year to date
-78.73%
1 year
-79.17%
5 years
-95.56%
10 years
-95.56%
Upgrade to unlock
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
100%
Negative
Positive
Neutral
Negative
Neutral
Seeking Alpha
22 days ago
Synergy CHC Corp. (SNYR) Q4 2025 Earnings Call Transcript
Synergy CHC Corp. (SNYR) Q4 2025 Earnings Call Transcript
Neutral
GlobeNewsWire
22 days ago
Synergy CHC Corp. Reports Fourth Quarter and Full Year 2025 Financial Results
NORTH WINDHAM, Maine, April 01, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a consumer health and wellness company, is announcing its financial results for the three and twelve months ended December 31, 2025.
Neutral
GlobeNewsWire
24 days ago
Synergy CHC Corp. Announces Date Change of Fourth Quarter and Full Year 2025 Earnings and Conference Call
WESTBROOK, Maine, March 30, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced an updated date for the release of its fourth quarter and full year financial results ended December 31, 2025. The Company will now report its financial results on Wednesday, April 1, 2026, before the open of market trading.
Neutral
GlobeNewsWire
1 month ago
Synergy CHC Corp. Announces Fourth Quarter and Full Year 2025 Earnings and Conference Call Information
WESTBROOK, Maine, March 17, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced that it plans to release financial results for the fourth quarter and full year ended December 31, 2025, on Tuesday, March 31, 2026, before the open of market trading.
Neutral
GlobeNewsWire
2 months ago
Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor® Functional Beverage Distribution Across Canada Through Walmart Canada and McKesson Canada
WESTBROOK, Maine, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced a major expansion of its FOCUSfactor® functional beverage portfolio across Canada, building on the successful launch of FOCUSfactor's supplement SKUs at Walmart Canada and through McKesson Canada during Q4 2025, with sell-through and consumer feedback supporting category expansion.
Neutral
Seeking Alpha
5 months ago
Synergy CHC Corp. (SNYR) Q3 2025 Earnings Call Transcript
Synergy CHC Corp. ( SNYR ) Q3 2025 Earnings Call November 13, 2025 9:00 AM EST Company Participants Jack Ross - CEO & Chairman Jaime Fickett - Chief Financial Officer Conference Call Participants Greg Robles Sean McGowan - ROTH Capital Partners, LLC, Research Division Presentation Operator Good morning, everyone, and thank you for participating in today's conference call to discuss Synergy CHC Corporation's Financial Results for the Third Quarter ended September 30, 2025. Joining us today are Synergy's CEO, Jack Ross; CFO, Jamie Fickett; and Greg Robles with Investor Relations.
Positive
Zacks Investment Research
5 months ago
Synergy CHC Corp. (SNYR) Meets Q3 Earnings Estimates
Synergy CHC Corp. (SNYR) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.1 per share a year ago.
Neutral
GlobeNewsWire
5 months ago
Synergy CHC Corp Expands FOCUSfactor® Functional Beverage Distribution Across Arkansas Through Partnership with C&M Sales
WESTBROOK, Maine, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR), a leading consumer health and wellness company, today announced a strategic distribution partnership with C&M Sales (Central and Moon Distributors), one of the largest and most established beverage distributors in Arkansas. The partnership expands statewide availability of FOCUSfactor® Focus + Energy rapidly growing functional beverages and shots, reinforcing Synergy's momentum in the fast-growing functional beverage category.
Neutral
GlobeNewsWire
7 months ago
Synergy CHC Corp. (NASDAQ: SNYR) Partners with AlaBev to Launch FOCUSfactor® Beverages in 5,000+ Retail Outlets Across Alabama
WESTBROOK, Maine, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR), a leading consumer health and wellness company, today announced a strategic distribution partnership with AlaBev, one of the Southeast's premier beverage distributors, to expand retail availability of its flagship FOCUSfactor® Focus + Energy functional beverage line and brain-health energy shots.
Neutral
GlobeNewsWire
7 months ago
Synergy CHC Corp. Announces the Closing of its $4.375 Million Public Offering
WESTBROOK, Maine, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (Nasdaq: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced the closing of an underwritten public offering of 1,750,000 shares of common stock at a public offering price of $2.50 per share for aggregate gross proceeds of $4.375 million prior to deducting underwriting discounts and commissions, and other offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 262,500 shares at the public offering price less the underwriting discounts and commissions.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close